Current and historical daily PE Ratio for Takeda Pharmaceutical Co Ltd (
) from 2010 to Apr 24 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Takeda Pharmaceutical stock (TAK) PE ratio as of Apr 24 2024 is 32.91.
More Details
Takeda Pharmaceutical Co Ltd (TAK) PE Ratio (TTM) Chart
Takeda Pharmaceutical Co Ltd (TAK) PE Ratio (TTM) Historical Data
View and export this data going back to 2010. Start your Free Trial
Total 1214
- 1
- 2
- 3
- 4
- 5
- 6
- 14
| Takeda Pharmaceutical PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-04-25 | 32.9 | 2024-02-20 | 36.9 |
| 2024-04-23 | 33.3 | 2024-02-16 | 36.4 |
| 2024-04-22 | 33.2 | 2024-02-15 | 35.9 |
| 2024-04-19 | 32.9 | 2024-02-14 | 36.2 |
| 2024-04-18 | 32.7 | 2024-02-13 | 35.7 |
| 2024-04-17 | 32.7 | 2024-02-12 | 35.6 |
| 2024-04-16 | 32.9 | 2024-02-09 | 35.4 |
| 2024-04-15 | 32.8 | 2024-02-08 | 34.8 |
| 2024-04-12 | 33.3 | 2024-02-07 | 35.3 |
| 2024-04-11 | 33.8 | 2024-02-06 | 35.2 |
| 2024-04-10 | 33.8 | 2024-02-05 | 34.6 |
| 2024-04-09 | 34.0 | 2024-02-02 | 35.5 |
| 2024-04-08 | 34.0 | 2024-02-01 | 35.8 |
| 2024-04-05 | 33.9 | 2024-01-31 | 36.3 |
| 2024-04-04 | 33.5 | 2024-01-30 | 36.2 |
| 2024-04-03 | 33.7 | 2024-01-29 | 36.7 |
| 2024-04-02 | 33.7 | 2024-01-26 | 36.3 |
| 2024-04-01 | 34.0 | 2024-01-25 | 36.4 |
| 2024-03-28 | 34.5 | 2024-01-24 | 36.5 |
| 2024-03-27 | 35.3 | 2024-01-23 | 36.6 |
| 2024-03-26 | 35.8 | 2024-01-22 | 36.8 |
| 2024-03-25 | 35.2 | 2024-01-19 | 36.6 |
| 2024-03-22 | 35.9 | 2024-01-18 | 37.0 |
| 2024-03-21 | 35.7 | 2024-01-17 | 37.0 |
| 2024-03-20 | 36.2 | 2024-01-16 | 37.3 |
| 2024-03-19 | 35.9 | 2024-01-12 | 37.4 |
| 2024-03-18 | 36.2 | 2024-01-11 | 37.1 |
| 2024-03-15 | 36.0 | 2024-01-10 | 37.0 |
| 2024-03-14 | 35.7 | 2024-01-09 | 36.7 |
| 2024-03-13 | 35.9 | 2024-01-08 | 36.9 |
| 2024-03-12 | 35.8 | 2024-01-05 | 36.6 |
| 2024-03-11 | 36.2 | 2024-01-04 | 36.2 |
| 2024-03-08 | 36.7 | 2024-01-03 | 35.7 |
| 2024-03-07 | 37.0 | 2024-01-02 | 35.7 |
| 2024-03-06 | 36.5 | 2023-12-29 | 35.5 |
| 2024-03-05 | 35.8 | 2023-12-28 | 35.4 |
| 2024-03-04 | 36.0 | 2023-12-27 | 31.2 |
| 2024-03-01 | 36.2 | 2023-12-26 | 31.2 |
| 2024-02-29 | 36.3 | 2023-12-22 | 31.1 |
| 2024-02-28 | 36.4 | 2023-12-21 | 31.0 |
| 2024-02-27 | 36.9 | 2023-12-20 | 30.4 |
| 2024-02-26 | 36.8 | 2023-12-19 | 30.6 |
| 2024-02-23 | 36.4 | 2023-12-18 | 30.6 |
| 2024-02-22 | 36.4 | 2023-12-15 | 30.4 |
| 2024-02-21 | 36.7 | 2023-12-14 | 31.1 |
Takeda Pharmaceutical Co Ltd (TAK) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
Takeda Pharmaceutical Co Ltd
NAICS : 325412
SIC : 2834
ISIN : US8740602052
Share Class Description:
TAK: ADRCompare
Compare
Traded in other countries / regions
4502.JapanTAK.USATAK.MexicoTKDA.GermanyTKD.AustriaTAKP34.Brazil0RN3.UK IPO Date
2010-05-11Description
Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4 trillion in fiscal 2022. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with 50% derived from the U.S., 20% from Japan, 20% from Europe and Canada.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers